Medikit Limited Filleted accounts for Companies House (small and micro)

Medikit Limited

Unaudited financial statements

30 November 2025

Company Registration Number 02507796

Medikit Limited

Financial statements

year ended 30 November 2025

Contents	Pages

Balance sheet	1 to 2

Notes to the financial statements	3 to 6

Medikit Limited

Balance sheet

30 November 2025

	2025	2024
Note	£	£

Fixed assets

Tangible assets	5	20,149	16,388

Current assets

Stocks		126,116	142,408
Debtors	6	313,834	313,269
Investments	7	160,166	160,166
Cash at bank and in hand		57,019	30,380
		---------	---------
		657,135	646,223

Prepayments and accrued income	6,705	6,250

Creditors: amounts falling due within one year	8	167,094	151,017
		---------	---------
Net current assets		496,746	501,456
		---------	---------
Total assets less current liabilities		516,895	517,844

Creditors: amounts falling due after more than one year	9	18,384	22,323

Accruals and deferred income	32,369	34,139
	---------	---------
Net assets	466,142	461,382
	---------	---------

Medikit Limited

Balance sheet (continued)

30 November 2025

	2025	2024
Note	£	£

Capital and reserves

Called up share capital	1,000	1,000
Profit and loss account	465,142	460,382
	---------	---------
Shareholders funds	466,142	461,382
	---------	---------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the profit and loss account has not been delivered.

For the year ending 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;

- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

These financial statements were approved by the board of directors and authorised for issue on 12 May 2026 , and are signed on behalf of the board by:

Mr G P Marchington

Director

Company registration number: 02507796

Medikit Limited

Notes to the financial statements

year ended 30 November 2025

1. General information

The company is a private company limited by shares, registered in England. The address of the registered office is Unit 1 Newporte Business Park, Cardinal Close, Bishops Road, Lincoln.

2. Statement of compliance

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3. Accounting policies

3.1 Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

3.2 Revenue recognition

Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

3.3 Income tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date where transactions or events have occurred at that date that will result in an obligation to pay more, or a right to pay less or to receive more tax, with the following exception: deferred tax assets are recognised only to the extent that the directors consider that it is more likely than not that there will be suitable taxable profits from which the future reversal of the underlying timing differences can be deducted. Deferred tax is measured on an undiscounted basis at the tax rates that are expected to apply in the periods in which timing differences reverse, based on tax rates and laws enacted or substantively enacted at the balance sheet date.

3.4 Tangible assets

Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.

3.5 Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

Leasehold property	-	10% straight line
Fixtures and equipment	-	15% reducing balance
Office equipment	-	15% reducing balance

3.6 Impairment of fixed assets

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.

3.7 Stocks

Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.

3.8 Defined contribution plans

Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.

4. Employee numbers

The average number of persons employed by the company during the year amounted to 7 (2024: 8 ).

5. Tangible assets

Land and buildings	Fixtures and equipment	Office equipment	Total
£	£	£	£

Cost
At 1 December 2024	65,176	32,626	16,504	114,306
Additions	–	2,485	5,717	8,202
Disposals	–	–	( 7,795)	( 7,795)
	--------	--------	--------	---------
At 30 November 2025	65,176	35,111	14,426	114,713
	--------	--------	--------	---------
Depreciation
At 1 December 2024	65,176	21,827	10,915	97,918
Charge for the year	–	1,651	1,782	3,433
Disposals	–	–	( 6,787)	( 6,787)
	--------	--------	--------	---------
At 30 November 2025	65,176	23,478	5,910	94,564
	--------	--------	--------	---------
Carrying amount
At 30 November 2025	–	11,633	8,516	20,149
	--------	--------	--------	---------
At 30 November 2024	–	10,799	5,589	16,388
	--------	--------	--------	---------

6. Debtors

	2025	2024
	£	£

Trade debtors	122,798	122,233
Other debtors	191,036	191,036
	---------	---------
	313,834	313,269
	---------	---------

7. Investments

	2025	2024
	£	£

Other investments	160,166	160,166
	---------	---------

8. Creditors: amounts falling due within one year

	2025	2024
	£	£

Bank loans and overdrafts	3,939	3,939
Trade creditors	41,191	78,980
Corporation tax	2,171	1,706
Social security and other taxes	16,721	10,226
Other creditors	103,072	56,166
	---------	---------
	167,094	151,017
	---------	---------

9. Creditors: amounts falling due after more than one year

	2025	2024
	£	£

Bank loans and overdrafts	18,384	22,323
	--------	--------